Chongqing Boer Animal Pharmaceutical Co., Ltd. (Boer Veterinary Medicine) is a national high-tech enterprise under the British Bull International Pharmaceutical Co., Ltd. Its brother company is Chongqing Boer Biological Medicine Co., Ltd. Boer Veterinary Medicine is a large GMP enterprise specializing in the international production of animal health drugs, integrating scientific research, development, production, sales and service. In 2012, it successfully passed the GMP certification of veterinary drugs issued by the Ministry of Agriculture of the People's Republic of China. At present, it can produce nearly 100 varieties of 9 dosage forms, including small volume water injection, large volume non intravenous injection, oral liquid, granules, tablets, powders, powders, premixes, powder injections, etc, More than 40 products have obtained the global free sales license, which can meet the needs of users at different levels. In 2013, the BULLVET trademark obtained the registration certificate from the State Administration for Industry and Commerce, and then was registered in 45 countries around the world. At present, it has obtained the registration license from the European Union, Japan, Canada and Australia; In 2014, the products entered 22 countries in the world, and 10 countries are under registration; At present, the company maintains good trade relations with Saudi Arabia, Egypt, Jordan, Chile, Nigeria, Sudan, Tanzania and other countries.